By BY REBECCA ROBBINS AND PAM BELLUCK from NYT Health The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms. https://ift.tt/3wpL7KI
8 Temmuz 2021 Perşembe
In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug
By BY REBECCA ROBBINS AND PAM BELLUCK from NYT Health The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms. https://ift.tt/3wpL7KI
Kaydol:
Kayıt Yorumları (Atom)
Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic
By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...
-
By BY EMILY ANTHES from NYT Health The F.D.A. authorized a breath-based test made by a small Texas company, which said it hoped that mobile...
-
By BY CARL ZIMMER from NYT Health https://ift.tt/2IHUMZY
-
https://ift.tt/2qR64Cz
Hiç yorum yok:
Yorum Gönder